Company · Healthtech & Bio

MIMO Biosciences

mimobiosciences.com ↗ ·Pamplona ·Seed

MIMO Biosciences is a contract research organization (CRO) specialized in hematology and immuno-oncology, spun out of Cima Universidad de Navarra in February 2024 after twelve years of research in the hemato-oncology lab of Dr. José Ángel Martínez-Climent. It provides preclinical research services built on proprietary animal models (syngeneic models, GEMMs, PDX and humanized xenografts) that faithfully reproduce the genetic alterations of multiple myeloma, lymphomas and other hematological malignancies, serving pharma and biotech drug-development programs. It closed a first capital increase in November 2024 with Sanitas and private investors, and won the 2025 CaixaBank EmprendeXXI award as the highest-potential startup in Navarra. It is based in Pamplona (Navarra).

Founded

2024

Founders

News

Rounds

Investors

SectorsBiotech, Preclinical CRO, Oncology, Hematology, Life Sciences Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Profile updated 4 Sep 2026

Founders

José Ángel Martínez-Climent

Founder & Chief Scientific Officer

Ricardo Pérez Merino

CEO

Global models

No comparables on record yet.

Investors 3

Cima Universidad de Navarra

cima.cun.es ↗

Investor Spain

Gutinver

Investor Spain

Sanitas

www.sanitas.es ↗

Investor Spain

Funding rounds 1

Seed

Sanitas, Gutinver and other private investors became shareholders of MIMO Biosciences through a capital increase; the amount was not disclos…

2024-11-28

News & media

No coverage on record yet.